CHMP5 and infection: Paxlovid’s active ingredient nirmatrelvir (PF-07321332) through the warhead nitrile group forming a covalent bond with thiol of the catalytic dyad Cys145- His41 of 3CLpro inactivates the catalytic site and blocks cleavage of the spike protein, thus preventing infection [10,14,65].